Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Acetazolamide 💬1件: Acetazolamide1件: Acetazolamide13件: CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA2,
CA4 💬
6件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬5件: 13, 90, 115, 155, 230 💬
2 Acetazolamide sodium 💬1件: Acetazolamide1件: Acetazolamide13件: CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA2,
CA4 💬
6件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬5件: 13, 90, 115, 155, 230 💬
3 Acetylcysteine 💬1件: Acetylcysteine1件: Acetylcysteine--10件: 34, 51, 53, 85, 94, 97, 193, 233, 298, 299 💬
4 Aflibercept 💬1件: Aflibercept1件: Aflibercept3件: PGF,
VEGFA,
VEGFB 💬
23件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬2件: 90, 166 💬
5 Betamethasone 💬1件: Betamethasone1件: Betamethasone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 28, 83, 90, 96, 235 💬
6 Betamethasone acetate 💬1件: Betamethasone1件: Betamethasone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 28, 83, 90, 96, 235 💬
7 Betamethasone benzoate 💬1件: Betamethasone1件: Betamethasone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 28, 83, 90, 96, 235 💬
8 Betamethasone dipropionate 💬1件: Betamethasone1件: Betamethasone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 28, 83, 90, 96, 235 💬
9 Betamethasone sodium phosphate 💬1件: Betamethasone1件: Betamethasone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 28, 83, 90, 96, 235 💬
10 Betamethasone valerate 💬1件: Betamethasone1件: Betamethasone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 28, 83, 90, 96, 235 💬
11 Brimonidine 💬1件: Brimonidine1件: Brimonidine tartrate3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
12 Brimonidine tartrate 💬1件: Brimonidine1件: Brimonidine tartrate3件: ADRA2A,
ADRA2B,
ADRA2C 💬
4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
13 Cannabis 💬1件: Medical Cannabis2件: Cannabis; Medical cannabis--6件: 6, 13, 46, 90, 96, 97 💬
14 Cefazolin 💬1件: Cefazolin1件: Cefazolin--1件: 291 💬
15 Cefazolin sodium 💬1件: Cefazolin1件: Cefazolin--1件: 291 💬
16 Cefuroxime 💬1件: Cefuroxime3件: Cefuroxim; Cefuroxima; Cefuroxime--3件: 90, 97, 299 💬
17 Cefuroxime axetil 💬1件: Cefuroxime3件: Cefuroxim; Cefuroxima; Cefuroxime--3件: 90, 97, 299 💬
18 Cefuroxime sodium 💬1件: Cefuroxime3件: Cefuroxim; Cefuroxima; Cefuroxime--3件: 90, 97, 299 💬
19 Cholesterol 💬1件: Cholesterol1件: Cholesterol--5件: 19, 90, 160, 222, 310 💬
20 Corn starch 💬1件: Starch, corn2件: Corn starch; Cornstarch--3件: 49, 97, 257 💬
21 Cysteine hydrochloride 💬1件: Cysteine2件: Cysteine; Cysteine hydrochloride--3件: 90, 254, 337 💬
22 Dexamethasone 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
23 Dexamethasone phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
24 Dexamethasone sodium phosphate 💬1件: Dexamethasone2件: Dexamethasone; Dexamethasone sodium phosphate1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬23件: 13, 14, 16, 19, 28, 35, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
25 Divalproex sodium 💬1件: Valproic acid3件: Valproate; Valproate sodium; Valproic acid7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬
16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
26 Dorzolamide 💬1件: Dorzolamide1件: Dorzolamide13件: CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA2,
CA4 💬
6件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬1件: 90 💬
27 Dorzolamide hydrochloride 💬1件: Dorzolamide1件: Dorzolamide13件: CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA2,
CA4 💬
6件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬1件: 90 💬
28 Fluocinolone acetonide 💬1件: Fluocinolone acetonide1件: Fluocinolone acetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 90 💬
29 Ginkgo 💬1件: Ginkgo biloba2件: Ginkgo biloba; Tanakan--3件: 13, 18, 47 💬
30 Hydroxychloroquine 💬1件: Hydroxychloroquine2件: Hydroxychloroquine; Hydroxychloroquine sulfate--26件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
31 Hydroxychloroquine sulfate 💬1件: Hydroxychloroquine2件: Hydroxychloroquine; Hydroxychloroquine sulfate--26件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
32 Isopropyl unoprostone 💬1件: Unoprostone1件: Unoprostone1件: PTGFR 💬 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 90 💬
33 L-Cysteine 💬1件: Cysteine2件: Cysteine; Cysteine hydrochloride--3件: 90, 254, 337 💬
34 Levodopa 💬1件: Levodopa2件: L-dopa; Levodopa5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 6, 17, 140, 201 💬
35 Melatonin 💬1件: Melatonin1件: Melatonin2件: MTNR1A,
MTNR1B 💬
2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬16件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
36 Minocycline 💬1件: Minocycline3件: Minocycline; Minocycline hydrochloride; Minomycin--15件: 2, 6, 8, 13, 46, 84, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
37 Minocycline hydrochloride 💬1件: Minocycline3件: Minocycline; Minocycline hydrochloride; Minomycin--15件: 2, 6, 8, 13, 46, 84, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
38 Nilvadipine 💬1件: Nilvadipine1件: Nilvadipine4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 90 💬
39 Omeprazole 💬1件: Omeprazole3件: Omeprazol; Omeprazole; Omeprazole magnesium2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬14件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298 💬
40 Omeprazole magnesium 💬1件: Omeprazole3件: Omeprazol; Omeprazole; Omeprazole magnesium2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬14件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298 💬
41 Omeprazole sodium 💬1件: Omeprazole3件: Omeprazol; Omeprazole; Omeprazole magnesium2件: ATP4A,
ATP4B 💬
3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬14件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298 💬
42 Prednisone 💬1件: Prednisone2件: Prednisona; Prednisone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
43 Tobramycin 💬1件: Tobramycin5件: Tobramicina; Tobramycin; Tobramycin sulfate; Tobramycine; Tobramycinum--1件: 299 💬
44 Tobramycin sulfate 💬1件: Tobramycin5件: Tobramicina; Tobramycin; Tobramycin sulfate; Tobramycine; Tobramycinum--1件: 299 💬
45 Tocopherol 💬1件: Tocopherol2件: Tocoferol; Tocopherol--3件: 90, 257, 298 💬
46 Triamcinolone 💬1件: Triamcinolone3件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 46, 53, 56, 90, 96, 107, 226, 298 💬
47 Triamcinolone acetonide 💬1件: Triamcinolone3件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 46, 53, 56, 90, 96, 107, 226, 298 💬
48 Triamcinolone diacetate 💬1件: Triamcinolone3件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 46, 53, 56, 90, 96, 107, 226, 298 💬
49 Triamcinolone hexacetonide 💬1件: Triamcinolone3件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 46, 53, 56, 90, 96, 107, 226, 298 💬
50 Unoprostone 💬1件: Unoprostone1件: Unoprostone1件: PTGFR 💬 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 90 💬
51 Valproate sodium 💬1件: Valproic acid3件: Valproate; Valproate sodium; Valproic acid7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬
16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
52 Valproic acid 💬1件: Valproic acid3件: Valproate; Valproate sodium; Valproic acid7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬
16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
53 Vitamin A 💬1件: Vitamin A1件: Vitamin A2件: RARA,
RARB 💬
8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬3件: 13, 53, 90 💬
54 Vitamin A oil 💬1件: Vitamin A1件: Vitamin A--3件: 13, 53, 90 💬
55 Vitamin E 💬1件: Vitamin E2件: Alpha-tocopherol; Vitamin E--6件: 2, 19, 20, 49, 90, 206 💬